The dental industry continues its rapid digital transformation as Orca Dental AI announced that its CephX platform has received FDA Class II 510(k) clearance for 3D imaging, adding to its existing 2D capabilities. This regulatory milestone makes CephX the only orthodontic AI diagnostic support platform with FDA clearance for both 2D and 3D imaging worldwide. The newly cleared CEPHX3D system enables clinicians to leverage AI-driven analysis for CBCT segmentation of the mandible, maxilla, full dentition, and inferior alveolar nerve, along with interactive 3D visualization and volumetric measurement tools. Alongside this clearance, Orca Dental AI has expanded strategic integrations with DEXIS and Greyfinch, embedding AI-powered cephalometric analysis into leading imaging and practice management ecosystems. These developments strengthen connected AI diagnostic platforms designed to support orthodontists and dental specialists with faster analysis, improved visualization, and more efficient clinical workflows. As the global digital dentistry market continues to expand, projected to reach approximately $7.2 billion in 2026 and grow to $13.7 billion by 2033, AI-powered diagnostics are increasingly becoming standard across clinical settings.
At Shenzhen Best Dental Lab, we closely monitor these technological breakthroughs to ensure our manufacturing processes align with evolving clinical standards. As a premier dental lab in China, we integrate cutting-edge digital workflows and advanced materials to deliver restorations that meet the diagnostic capabilities of tomorrow. Partner with us for precision craftsmanship backed by innovation.